Long‐Term Outcomes After Transcatheter and Surgical Aortic Valve Replacement in Patients With Cirrhosis: A Guide for the Hepatologist
- 20 February 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 72 (5) , 1735-1746
Abstract
Background and Aims: Hepatologists often determine whether transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) is preferred for patients with cirrhosis and severe aortic stenosis. The goal of this cohort study is to compare outcomes following TAVR and SAVR in patients with cirrhosis to inform the preferred intervention. Approach and Results: Prospectively collected data on 105 consecutive patients with cirrhosis and aortic stenosis who underwent TAVR (n = 55) or SAVR (n = 50) between 2008 and 2016 were reviewed retrospectively. Two control groups were included: 2,680 patients without cirrhosis undergoing TAVR and SAVR and 17 patients with cirrhosis who received medical therapy alone. Among the 105 patients with cirrhosis, the median Society of Thoracic Surgeons score was 3.8% (1.5, 6.9), and the median Model for End‐Stage Liver Disease (MELD) score was 11.6 (9.4, 14.0). The TAVR group had similar in‐hospital (1.8% vs. 2.0%) and 30‐day mortality (3.6% vs. 4.2%) as the SAVR group. During the median follow‐up of 3.8 years (95% confidence interval, 3.0‐6.9), there were 63 (60%) deaths. MELD score (adjusted hazard ratio, 1.13; 95% confidence interval, 1.05‐1.21; P = 0.002) was an independent predictor of long‐term survival. In the subgroup of patients with MELD score P = 0.047). However, in those with MELD score ≥12, survival after TAVR, SAVR, and medical therapy was similar (1.3 vs. 2.1 vs. 1.6 years, respectively; P = 0.53). Conclusion: In select patients with cirrhosis, both TAVR and SAVR have acceptable and comparable short‐term outcomes. MELD score, but not Society of Thoracic Surgeons score, independently predicts long‐term survival after TAVR and SAVR. For patients with MELD score <12, SAVR is a preferred procedure; however, neither procedure appears superior to medical therapy in patients with MELD score ≥12.Keywords
This publication has 23 references indexed in Scilit:
- Transcatheter Aortic Valve Replacement in Patients with CirrhosisJournal of Cardiac Surgery, 2013
- Predictive Risk Factors for Patients With Cirrhosis Undergoing Heart SurgeryThe Annals of Thoracic Surgery, 2012
- Safety of Cardiac Surgery for Patients With Cirrhosis and Child–Pugh Scores Less Than 8Clinical Gastroenterology and Hepatology, 2012
- Do patients with liver cirrhosis undergoing cardiac surgery have acceptable outcomes?☆Interactive CardioVascular and Thoracic Surgery, 2010
- Risk prediction and outcomes in patients with liver cirrhosis undergoing open-heart surgery☆European Journal of Cardio-Thoracic Surgery, 2010
- The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Part 2—Isolated Valve SurgeryThe Annals of Thoracic Surgery, 2009
- Early and Late Outcome of Cardiac Surgery in Patients with Liver CirrhosisLiver Transplantation, 2007
- Risk Factors for Mortality After Surgery in Patients With CirrhosisGastroenterology, 2007
- MELD-XI: A rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapyLiver Transplantation, 2006
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001